Riluzole prodrugs for melanoma and ALS: design, synthesis, and in vitro metabolic profiling.
about
Recent progress in the discovery of small molecules for the treatment of amyotrophic lateral sclerosis (ALS)Intramolecular Rearrangement of α-Amino Acid Amide Derivatives of 2-AminobenzothiazolesIs the risk of motor neuron disease increased or decreased after cancer? An Australian case-control study.PET imaging studies show enhanced expression of mGluR5 and inflammatory response during progressive degeneration in ALS mouse model expressing SOD1-G93A geneCurrent Therapy of Drugs in Amyotrophic Lateral Sclerosis.Glutamate signaling in benign and malignant disorders: current status, future perspectives, and therapeutic implications.A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma.
P2860
Q24613709-F503270A-364E-4B30-A782-686DAFE3EEC2Q33877630-0F43AB04-F604-4E90-9609-0A14414A87E4Q33946187-FEEE2504-303C-4D60-B6D4-3D4C989CC1DCQ36311020-0725BAAE-3ACD-402E-9CF8-525B59DCEBA1Q36925891-366FA4D4-F5BF-4F37-BE9E-6E6855F72C6FQ37121338-F655C3B6-1B36-4EE4-876A-EBC73B60652BQ49907440-BEEABE75-CC99-4BC9-860B-5C19CC87A632
P2860
Riluzole prodrugs for melanoma and ALS: design, synthesis, and in vitro metabolic profiling.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Riluzole prodrugs for melanoma ...... in vitro metabolic profiling.
@ast
Riluzole prodrugs for melanoma ...... in vitro metabolic profiling.
@en
type
label
Riluzole prodrugs for melanoma ...... in vitro metabolic profiling.
@ast
Riluzole prodrugs for melanoma ...... in vitro metabolic profiling.
@en
prefLabel
Riluzole prodrugs for melanoma ...... in vitro metabolic profiling.
@ast
Riluzole prodrugs for melanoma ...... in vitro metabolic profiling.
@en
P2093
P2860
P1476
Riluzole prodrugs for melanoma ...... in vitro metabolic profiling.
@en
P2093
Allen B Reitz
Benjamin E Blass
Brian A Wall
Carmen Fernandez-Metzler
Garry R Smith
Jay Wrobel
Jeffrey C Pelletier
Mark E McDonnell
Matthew D Vera
Richard C King
P2860
P304
P356
10.1016/J.BMC.2012.07.004
P407
P577
2012-07-21T00:00:00Z